2D Layered Double Hydroxide Nanoparticles: Recent Progress toward Preclinical/Clinical Nanomedicine

Двумерные наночастицы слоистых двойных гидроксидов: последние достижения на пути к доклинической и клинической наномедицине
Li Li, Zi Gu, Zhi Ping Xu, Zhenbang Cao, Bei Li, Luyao Sun
2019-08-20

2D nanomaterialsLDH nanomedicinegene-based and protein-based vaccineslayered double hydroxide nanoparticlessurface engineering
Abstract 2D nanomaterials represent one of the next‐generation biomaterials with versatile physicochemical advantages that allow for diverse biomedical applications in disease diagnosis, prevention, and treatment. In particular, layered double hydroxide (LDH) nanoparticles, as a typical 2D nanomaterial, have recently shown unprecedented advances in controllable and simplified chemical construction, versatile surface engineering, and comprehensive biological investigation. To realize in vivo biomedical applications, recent efforts have been substantially devoted to a few critical aspects of LDH nanomedicine including nanoparticle stability in physiological environments, accumulation at the disease‐targeted site, selective biological response to the nanoparticle, systematic biosafety examination, integration with multiple diagnostic and therapeutic modalities, and the adjuvant activity and suitability for gene‐based and protein‐based vaccines, which are herein comprehensively reviewed. The challenges and future development strategies of LDH nanomedicine are also discussed toward practical biomedical applications to benefit patients.
1
LDH nanomedicine is increasingly integrated with multiple diagnostic and therapeutic modalities and investigated as an adjuvant for gene- and protein-based vaccines.
2
Layered double hydroxide nanoparticles are highlighted as versatile two-dimensional biomaterials for disease diagnosis, prevention, and treatment.
3
Progress toward in vivo applications focuses on physiological stability, disease-site accumulation, selective biological responses, and systematic biosafety evaluation.
4
Recent advances have enabled more controllable and simplified LDH chemical construction, versatile surface engineering, and broader biological investigation.
5
Translation to practical biomedical applications remains challenged by nanoparticle stability, targeting, biological selectivity, safety, and the need for optimized development strategies.

layered double hydroxide (LDH) nanoparticles for biomedical applications

their physicochemical construction and surface engineering, physiological stability, disease-site accumulation, selective biological responses, biosafety, multimodal diagnostic and therapeutic integration, and adjuvant suitability for gene- and protein-based vaccines

Publication Details
Publication Date
2019-08-20
Journal
Publisher
ISSN
Cited by
150
Access Type
Author Information
Authors
Li Li
Zi Gu
Zhi Ping Xu
Zhenbang Cao
Bei Li
Luyao Sun
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%